Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,1.0008670919981124e-07,7.051851851851852,113.65631070965392,"['RPL41', 'RPS3A', 'RPL23A', 'RPL9', 'RPL7A', 'RPS15A', 'RPS18', 'RPL14', 'RPL13', 'RPL15', 'FAU', 'RPL26', 'RPS2', 'RPS27A', 'RPL19', 'RPS12']",6.105289261188486e-06,0,0,16
2,Proximal tubule transport WP4917,0.009915293929550732,32.794117647058826,151.3014621426973,"['SLC1A1', 'SLC3A1']",0.3000269599986171,0,0,2
3,NO metabolism in cystic fibrosis WP4947,0.059021697048908285,inf,inf,['PRMT8'],0.3000269599986171,0,0,1
4,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.059021697048908285,inf,inf,['ALOX12'],0.3000269599986171,0,0,1
5,Osteoblast Signaling WP322,0.059021697048908285,inf,inf,['TNFRSF11B'],0.3000269599986171,0,0,1
6,Osteoclast Signaling WP12,0.059021697048908285,inf,inf,['TNFRSF11B'],0.3000269599986171,0,0,1
7,Metabolism of alpha-linolenic acid WP4586,0.059021697048908285,inf,inf,['ALOX12'],0.3000269599986171,0,0,1
8,Urea cycle and related diseases WP4571,0.059021697048908285,inf,inf,['GLS2'],0.3000269599986171,0,0,1
9,Vitamin B12 Disorders WP4271,0.059021697048908285,inf,inf,['CUBN'],0.3000269599986171,0,0,1
10,NAD Biosynthesis II (from tryptophan) WP2485,0.059021697048908285,inf,inf,['HAAO'],0.3000269599986171,0,0,1
11,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.059021697048908285,inf,inf,['ELOB'],0.3000269599986171,0,0,1
12,Homologous recombination WP186,0.059021697048908285,inf,inf,['POLD4'],0.3000269599986171,0,0,1
13,Dual hijack model of Vif in HIV infection WP3300,0.11460681678431581,16.159420289855074,35.00531177396102,['ELOB'],0.39169654295794504,0,0,1
14,Biomarkers for urea cycle disorders WP4583,0.11460681678431581,16.159420289855074,35.00531177396102,['GLS2'],0.39169654295794504,0,0,1
15,Pyrimidine metabolism and related diseases WP4225,0.11460681678431581,16.159420289855074,35.00531177396102,['GLS2'],0.39169654295794504,0,0,1
16,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.15474930285782354,3.2529411764705882,6.069821920170356,"['ATP5IF1', 'COX7A1']",0.39169654295794504,0,0,2
17,DNA Mismatch Repair WP531,0.16695262486732082,8.072463768115941,14.450074941505468,['POLD4'],0.39169654295794504,0,0,1
18,DNA Replication WP466,0.16695262486732082,8.072463768115941,14.450074941505468,['POLD4'],0.39169654295794504,0,0,1
19,Eicosanoid Synthesis WP167,0.16695262486732082,8.072463768115941,14.450074941505468,['ALOX12'],0.39169654295794504,0,0,1
20,Nucleotide Excision Repair WP4753,0.16695262486732082,8.072463768115941,14.450074941505468,['POLD4'],0.39169654295794504,0,0,1
21,Kynurenine Pathway and links to Cellular Senescence WP5044,0.16695262486732082,8.072463768115941,14.450074941505468,['HAAO'],0.39169654295794504,0,0,1
22,Base Excision Repair WP4752,0.16695262486732082,8.072463768115941,14.450074941505468,['POLD4'],0.39169654295794504,0,0,1
23,Tryptophan catabolism leading to NAD+ production WP4210,0.16695262486732082,8.072463768115941,14.450074941505468,['HAAO'],0.39169654295794504,0,0,1
24,Urea cycle and associated pathways WP4595,0.16695262486732082,8.072463768115941,14.450074941505468,['GLS2'],0.39169654295794504,0,0,1
25,Urea cycle and metabolism of amino groups WP497,0.16695262486732082,8.072463768115941,14.450074941505468,['ARG2'],0.39169654295794504,0,0,1
26,Modulators of TCR signaling and T cell activation WP5072,0.16695262486732082,8.072463768115941,14.450074941505468,['ELOB'],0.39169654295794504,0,0,1
27,DNA Repair Pathways Full Network WP4946,0.21624530373160802,5.3768115942028984,8.233736615133923,['POLD4'],0.4255149525041319,0,0,1
28,Inflammatory Response Pathway WP453,0.21624530373160802,5.3768115942028984,8.233736615133923,['LAMB1'],0.4255149525041319,0,0,1
29,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.21624530373160802,5.3768115942028984,8.233736615133923,['TNFRSF11B'],0.4255149525041319,0,0,1
30,Glycogen Synthesis and Degradation WP500,0.21624530373160802,5.3768115942028984,8.233736615133923,['HKDC1'],0.4255149525041319,0,0,1
31,Monoamine Transport WP727,0.21624530373160802,5.3768115942028984,8.233736615133923,['TNFRSF11B'],0.4255149525041319,0,0,1
32,Nephrotic syndrome WP4758,0.2626604940321518,4.028985507246377,5.386322432884242,['CUBN'],0.4712438275282724,0,0,1
33,Tryptophan metabolism WP465,0.2626604940321518,4.028985507246377,5.386322432884242,['HAAO'],0.4712438275282724,0,0,1
34,Type 2 papillary renal cell carcinoma WP4241,0.2626604940321518,4.028985507246377,5.386322432884242,['ELOB'],0.4712438275282724,0,0,1
35,Amino Acid metabolism WP3925,0.30636387485486827,3.2202898550724637,3.8095441281847937,['ARG2'],0.5191165657263046,0,0,1
36,Globo Sphingolipid Metabolism WP1424,0.30636387485486827,3.2202898550724637,3.8095441281847937,['ST6GAL2'],0.5191165657263046,0,0,1
37,RANKL/RANK signaling pathway WP2018,0.347511718996469,2.681159420289855,2.8338699246491177,['TNFRSF11B'],0.5729247259130975,0,0,1
38,Alpha 6 Beta 4 signaling pathway WP244,0.38625141912855726,2.2960662525879916,2.1841715430918787,['LAMB1'],0.5996753738986701,0,0,1
39,Vitamin B12 metabolism WP1533,0.38625141912855726,2.2960662525879916,2.1841715430918787,['CUBN'],0.5996753738986701,0,0,1
40,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.42272198487939033,2.0072463768115942,1.7283205486931252,['IFI27L2'],0.5996753738986701,0,0,1
41,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.42272198487939033,2.0072463768115942,1.7283205486931252,['BEX3'],0.5996753738986701,0,0,1
42,Mesodermal commitment pathway WP2857,0.42272198487939033,2.0072463768115942,1.7283205486931252,['ARL4A'],0.5996753738986701,0,0,1
43,Pyrimidine metabolism WP4022,0.42272198487939033,2.0072463768115942,1.7283205486931252,['POLD4'],0.5996753738986701,0,0,1
44,Selenium Micronutrient Network WP15,0.4570545130366479,1.7826086956521738,1.3956981320419521,['SELENOM'],0.6336437567098983,0,0,1
45,Apoptosis Modulation and Signaling WP1772,0.48937263150591,1.6028985507246376,1.1454810776873823,['TNFRSF11B'],0.6341473608975485,0,0,1
46,p53 transcriptional gene network WP4963,0.48937263150591,1.6028985507246376,1.1454810776873823,['GLS2'],0.6341473608975485,0,0,1
47,Complement system WP2806,0.48937263150591,1.6028985507246376,1.1454810776873823,['LAMB1'],0.6341473608975485,0,0,1
48,Ectoderm Differentiation WP2858,0.5197929187684824,1.4558629776021081,0.9526072223259282,['TNFRSF11B'],0.6341473608975485,0,0,1
49,Integrated breast cancer pathway WP1984,0.5197929187684824,1.4558629776021081,0.9526072223259282,['FAU'],0.6341473608975485,0,0,1
50,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.5197929187684824,1.4558629776021081,0.9526072223259282,['TNFRSF11B'],0.6341473608975485,0,0,1
51,Small cell lung cancer WP4658,0.5753734226050055,1.229654403567447,0.6796742789820291,['LAMB1'],0.6622222411114214,0,0,1
52,Circadian rhythm related genes WP3594,0.5753734226050055,1.229654403567447,0.6796742789820291,['RPS27A'],0.6622222411114214,0,0,1
53,Vitamin D Receptor Pathway WP2877,0.5753734226050055,1.229654403567447,0.6796742789820291,['TNFRSF11B'],0.6622222411114214,0,0,1
54,Calcium Regulation in the Cardiac Cell WP536,0.6007350072494712,1.1407867494824016,0.5813464806017484,['RGS17'],0.6662697353130499,0,0,1
55,Myometrial relaxation and contraction pathways WP289,0.6007350072494712,1.1407867494824016,0.5813464806017484,['RGS17'],0.6662697353130499,0,0,1
56,Nonalcoholic fatty liver disease WP4396,0.6880812071465954,0.8840579710144928,0.3305036706757308,['COX7A1'],0.7495170292132556,0,0,1
57,Focal Adhesion WP306,0.706790909929978,0.8367658276125095,0.29037481178549845,['LAMB1'],0.7563902720303273,0,0,1
58,IL-18 signaling pathway WP4754,0.7979343899007262,0.6324637681159421,0.14276535261588416,['TNFRSF11B'],0.8375898763117632,0,0,1
59,PI3K-Akt signaling pathway WP4172,0.8101279131540006,0.6075808249721293,0.12793411799167237,['LAMB1'],0.8375898763117632,0,0,1
60,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.8323797922879361,0.5631469979296067,0.1033185868463536,['LAMB1'],0.8462527888260684,0,0,1
61,VEGFA-VEGFR2 Signaling Pathway WP3888,0.9158893420679891,0.40022296544035674,0.03516348056605593,['RPL26'],0.9158893420679891,0,0,1
